WuXi Biologics Investor Relations Material
Latest events
H2 2024
WuXi Biologics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from WuXi Biologics (Cayman) Inc
Access all reports
WuXi Biologics (Cayman) Inc. is a global contract research, development, and manufacturing organization (CRDMO) focused on biologics. The company offers comprehensive services that span from biologic discovery and development to commercial manufacturing. Key offerings include protein generation, antibody development, assay development, and regulatory affairs. The company is headquartered in Wuxi, China, and its shares are listed on the Hong Kong Stock Exchange.
Key slides for WuXi Biologics (Cayman) Inc
H1 2024
WuXi Biologics (Cayman) Inc
H2 2024
WuXi Biologics (Cayman) Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
2269
Country
🇭🇰 Hong Kong